WSFS
ASND icon

Wilmington Savings Fund Society’s Ascendis Pharma A/S ASND Stock Holding History

Wilmington Savings Fund Society’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-203
Closed -$35K – 1417
2025
Q2 		$35K Hold
203
– – ﹤0.01% 1304
2025
Q1 		$31.6K Hold
203
– – ﹤0.01% 1329
2024
Q4 		$27.9K Hold
203
– – ﹤0.01% 1408
2024
Q3 		$30.3K Buy
+203
New +$27.4K ﹤0.01% 1361

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wilmington Savings Fund Society's ASND Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 203 shares — an estimated $35K sold.

Wilmington Savings Fund Society first reported a position in ASND in Q3 2024 and held it in 4 quarters. The position peaked at $35K in Q2 2025. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 203 Ascendis Pharma A/S shares in Q3 2025, an estimated $35K.
  • Wilmington Savings Fund Society first reported a position in Ascendis Pharma A/S in Q3 2024 and held it in 4 quarters.
  • Wilmington Savings Fund Society's Ascendis Pharma A/S position peaked at $35K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.